Bei Gene, Ltd. Leap Therapeutics, Inc. (LPTX) insider trading activity

LPTX Quotes by TradingView

Bei Gene, Ltd. is > 10% Shareholder of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 7.35 Million shares of LPTX, which is worth approximately $27.5 Million. The most recent transaction as insider was on Sep 24, 2021, when has been sold 2,543,800 shares (Common Stock) at a price of $2.85 per share, resulting in proceeds of $7,249,830. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.35M
0% 3M change
0% 12M change
Total Value Held $27.5 Million

BeiGene, Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 24 2021
BUY
Open market or private purchase
$7,249,830 $2.85 p/Share
2,543,800 Added 25.72%
7,348,437 Common Stock
BL

Bei Gene, Ltd.

> 10% Shareholder
Grand Cayman,

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPTX